Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9823
Title: Cancer patent scenario in Brazil: Analysis of competitive advantages
Authors: Avellar, William de Oliveira
Sant'Ana, João Maurício Brambati
Ferreira, Daniele Masterson Tavares Pereira
Alves, Flávia Vieira Guerra
Ponte, Veronica Aran
Ferreira, Carlos Gil Moreira
Keywords: Patent
Patente
Neoplasms
Neoplasias
Creativity
Criatividade
Health Care Economics and Organizations
Economia e Organizações de Saúde
Oncological drugs
Medicamentos oncológicos
Issue Date: 2017
Publisher: Journal of Cancer Policy
Abstract: The present study describes the geographical and sectorial profile of chemical and biotechnological patents, regarding prevention, diagnosis, and treatment for the most frequent cancer types in Brazil that are currently registered in the Brazilian National Institute of Industrial Property – INPI, from 1998 until 2013. The steps taken to generate competitive advantage in the Brazilian oncological drug market are discussed and an analytic sectional survey was performed using the INPI database. In addition, a literature review on technology and scientific development was conducted using the Porter’s Diamond of National Advantage model. From 503 requests for patents, 41.4% corresponded to breast cancer, 13.7% lung cancer, 38.6% prostate, and 6.4% cervical cancer. Regarding the sectors and countries involved, the vast majority (74.4%) came from the pharmaceutical industry: mainly from the USA and Switzerland. According to the analysis and the Porter Diamond Model, we concluded that Brazil is uncompetitive in cancer R&DI.
Description: Volume 12, June 2017, Pages 28-33
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/9823
ISSN: 2213-5383
Appears in Collections:Artigos de Periódicos da área de Enfermagem

Files in This Item:
File Description SizeFormat 
Cancer patent scenario in Brazil Analysis of competitive advantages..pdf514.01 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.